Enanta Pharmaceuticals
ENTA
#7512
Rank
S$0.52 B
Marketcap
S$18.25
Share price
-1.60%
Change (1 day)
94.43%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2025 (TTM): -S$0.12 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are S$64.8 Million. In 2024 the company made an earning of -S$0.13 Billion, an increase over its 2023 earnings that were of -S$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$0.12 Billion-9.48%
2024 -S$0.13 Billion-23.87%
2023 -S$0.17 Billion4.39%
2022 -S$0.16 Billion-4.4%
2021 -S$0.17 Billion91.12%
2020 -S$86.25 Million-407.13%
2019 S$28.08 M-78.63%
2018 S$0.13 B117.97%
2017 S$60.29 M-574.65%
2016 -S$12.71 Million-110.83%
2015 S$0.11 B-4.5%
2014 S$0.12 B-638.53%
2013 -S$22.82 Million-137.98%
2012 S$60.05 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
AbbVie
ABBV
S$2.14 B-2,025.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$41.82 B-37,685.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
S$5.75 B-5,276.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$29.80 B-26,889.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$10.37 B-9,419.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$21.19 B-19,149.33%๐Ÿ‡จ๐Ÿ‡ญ Switzerland